BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24747161)

  • 1. Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.
    Anselmo AC; Mitragotri S
    J Control Release; 2014 Sep; 190():531-41. PubMed ID: 24747161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced hitchhiking nanomaterials for biomedical applications.
    Wang Y; Sun SK; Liu Y; Zhang Z
    Theranostics; 2023; 13(14):4781-4801. PubMed ID: 37771786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ cellular hitchhiking of nanoparticles for drug delivery.
    Udofa E; Zhao Z
    Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches.
    Anselmo AC; Kumar S; Gupta V; Pearce AM; Ragusa A; Muzykantov V; Mitragotri S
    Biomaterials; 2015 Nov; 68():1-8. PubMed ID: 26241497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.
    Anselmo AC; Gupta V; Zern BJ; Pan D; Zakrewsky M; Muzykantov V; Mitragotri S
    ACS Nano; 2013 Dec; 7(12):11129-37. PubMed ID: 24182189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging methods in therapeutics using multifunctional nanoparticles.
    Habibi N; Quevedo DF; Gregory JV; Lahann J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1625. PubMed ID: 32196991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated delivery of synthetic nano- and microparticles.
    Ayer M; Klok HA
    J Control Release; 2017 Aug; 259():92-104. PubMed ID: 28189629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand density on nanoparticles: A parameter with critical impact on nanomedicine.
    Alkilany AM; Zhu L; Weller H; Mews A; Parak WJ; Barz M; Feliu N
    Adv Drug Deliv Rev; 2019 Mar; 143():22-36. PubMed ID: 31158406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
    Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
    Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
    Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
    Small; 2017 Mar; 13(10):. PubMed ID: 28026115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Applications of Nanoparticles in the Spine.
    Venugopal I; Mehta AI; Linninger AA
    Methods Mol Biol; 2020; 2059():121-143. PubMed ID: 31435918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.
    Yoo JW; Chambers E; Mitragotri S
    Curr Pharm Des; 2010 Jul; 16(21):2298-307. PubMed ID: 20618151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes.
    Trac N; Chung EJ
    Exp Biol Med (Maywood); 2021 Nov; 246(22):2358-2371. PubMed ID: 33957802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
    Brenner JS; Mitragotri S; Muzykantov VR
    Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.
    Huang RB; Mocherla S; Heslinga MJ; Charoenphol P; Eniola-Adefeso O
    Mol Membr Biol; 2010 Oct; 27(7):312-27. PubMed ID: 21028938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
    Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
    Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology for protein delivery: Overview and perspectives.
    Yu M; Wu J; Shi J; Farokhzad OC
    J Control Release; 2016 Oct; 240():24-37. PubMed ID: 26458789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.